Código QR

Policy for transitioning childhood-onset growth hormone deficiency from pediatric to adult endocrine care in Belgium

Growth hormone (GH) deficiency (GHD) in children and adolescents can vary in severity and origin, with GH replacement therapy proving effective in achieving genetic target height. Optimal outcomes are seen in those treated early and with higher doses. As patients approach adult height, priorities sh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Willem Staels, Jean De Schepper, Marianne Becker, Philippe Lysy, Daniel Klink, Karl Logghe, Marieken den Brinker, Anne Rochtus, Bruno Lapauw, Martine Cools, Orsalia Alexopoulou, Marie Bex, Bernard Corvilain, Laurent Crenier, Christophe De Block, Julian Donckier, Robert Hilbrands, Michel Ponchon, Guy T'Sjoen, Annick Van Den Bruel, Sara Vandewalle, Brigitte Velkeniers
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2024-09-01
Colección:Frontiers in Endocrinology
Materias:
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fendo.2024.1459998/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!